title: [Improvement in the outcome of visual impairment using low vision aids in children].
abstract: BACKGROUND
  Low visual aids (LVAs) are the simplest and the most economic method of reducing the consequences of visual impairment (VI). We evaluate prescribing of LVAs in order to improve the quality of life of visually impaired children.
  
  
  METHODS
  We retrospectively reviewed the notes of 113 patients (pts.) with VI (visual acuity (VA) 6/18 or worse or with visual field defects) who attended the Low Vision Clinic, F.D. Roosevelt Hospital in Banska Bystrica, between Jan 2000 - Dec 2005. There were 61 boys and 52 girls with ages ranging from < 1 year to < 19 years (mean age 9.4 years, median 9 years).
  
  
  RESULTS
  Of the 113 notes reviewed, only 109 of patients were cooperative in having their VA formally tested. Blindness (VA worse than 3/60) occurred in 31 pts. (28.4%) and Low vision (VA worse than 6/18 or equal to 3/60) in 67 (61.5%). Of the remaining 11 patients, 4 had gross field defects (and good VA), (indicating that the total number with Low vision was 71 (65%). The other 7 patients had either developmental delay or were too young to perform a formal visual field test. Blindness was caused by perinatal factors in 52% of cases, prenatal factors in 45% and postnatal factors in 3%. Low vision was caused in 74.6% of cases by prenatal factors. The causes of blindness according to the affected anatomical site were: optic nerve disease in 12 (39%), cerebral visual impairment (CVI) in 8 (26%), and retinal disease in 6 (20%). Low vision was caused by retinal disease in 23 (34.3%), lens pathology in 11 (16.5%) and CVI in 10(14.9%). 171 LVAs were prescribed to 74 patients (65%): 76 (44.4%) were magnifiers, 21 (12.3%) were hyperoculars or high adds, 65 (38%) were telescopes and 9 (5.5%) telescope extensions. An average of 1.5 devices was prescribed for each patient. Every patient who was prescribed an LVA had subjective and objective improvement of their visual function and functional vision.
  
  
  CONCLUSIONS
  Blindness occurred in almost one third of our patients which agrees with the worldwide accepted estimate. The LVA are improving the quality of life of visually impaired children. The prescribing of LVA depends on the individual: it is not possible to anticipate the optical power of the LVA that a patient will need simply from looking at their diagnosis and measuring their VA because there are so many different requirements depending on their age and visual demands.
authors.affiliation: Clinical and Academic Department of Ophthalmology, Great Ormond Street Hospital for Children, London, UK. GajdoE@gosh.nhs.uk
authors.forename: E
authors.initials: E
authors.lastname: Gajdosová
authors.forename: E
authors.initials: E
authors.lastname: Kukurová
authors.forename: A
authors.initials: A
authors.lastname: Gerinec
mesh_terms: D000293:Adolescent; D001766:Blindness / Q000209:etiology / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007909:Lenses; D008297:Male; D055096:Optical Devices; D015354:Vision, Low / Q000209:etiology / Q000628:therapy*; D014792:Visual Acuity; D055815:Young Adult